S. Sharma

Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer.

M. Gonen, N. Kemeny, L. Saltz, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other solid tumors.

R. Robles, J. Infante, M. Tortorici, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Development of inhalational agents for oncologic use.

M. Kris, Sunil Sharma, D. Vail, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I dose escalation study of AUY922, a novel HSP90 inhibitor, in patients with advanced solid malignancies.

G. Shapiro, K. Bhalla, C. Britten, 2016, Journal of Clinical Oncology.

Phase I study of RAD001 (everolimus), cetuximab, and irinotecan as second-line therapy in metastatic colorectal cancer (mCRC).

C. Garrett, T. Reid, J. Hecht, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A pilot pharmacokinetic study of oral azacitidine

H. Kantarjian, G. Garcia-Manero, M. Ward, 2008, Leukemia.

Impact of Switching Virologically Suppressed, HIV-1-Infected Patients from Twice-Daily Fixed-Dose Zidovudine/Lamivudine to Once-Daily Fixed-Dose Tenofovir Disoproxil Fumarate/Emtricitabine

R. Ebrahimi, P. Ruane, E. Dejesus, 2008, HIV Clinical Trials.

Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial

I. Pedley, S. Crabb, E. Clark, 2022, NIHR open research.